Latvijas Universitātes institucionālās kapacitātes attīstība
Browse by
ERAF 2.1.1.3.3.aktivitāte „Zinātnisko institūciju institucionālās kapacitātes attīstība” . Vienošanās Nr. 2DP/2.1.1.3.3/15/IPIA/VIAA/003. Projekta īstenošanas laiks: 01.03.2015.-31.12.2015.
Sub-communities within this community
Recent Submissions
-
Parameters for automated star identification
(Taylor&Francis, 2014) -
Sediment quality of the ecoregion Engure, Gulf of Riga, assessed by using ecotoxicity tests and biomarker responses
(Latvian Academy of Sciences, 2014) -
Recovering Genetic Resources of Some Legume Species of Latvian Origin by Plant Tissue Culture
(Latvian Academy of Sciences, 2013) -
STATBOX Concept for Simulation of Urban Phenomena
(Elsevier, 2013) -
Nail fold capillary diameter changes in acute systemic hypoxia
(Elsevier, 2014) -
Modeling and Query Language for Hospitals
(Springer, 2013) -
Lunasin-induced behavioural effects in mice: Focus on the dopaminergic system
(Elsevier, 2013)The present study for the first time is devoted to identify central effects of synthetic lunasin, a 43 amino acid peptide. A markedly expressed neuroleptic/cataleptic effect was observed at low (0.1–10 nmol/mouse) centrally ... -
Crystal structures of the Erp protein family members ErpP and ErpC from Borrelia burgdorferi reveal the reason for different affinities for complement regulator factor H
(Elsevier, 2015)Borrelia burgdorferi is the causative agent of Lyme disease, which can be acquired after the bite of an infected Ixodes tick. As a strategy to resist the innate immunity and to successfully spread and proliferate, B. ... -
A common promoter variant of the gene encoding cyclooxygenase-1 (PTGS1) is related to decreased incidence ofmyocardial infarction in patients with coronary artery disease
(Elsevier, 2011)Cyclooxigenase (COX)-1, formally known as prostanglandin endoperoxideH synthetase-1,mediates synthesis of prostaglandin H2,which is subsequently converted to various biologically active metabolites including thromboxane ... -
Association of reduced glyoxalase 1 activity and painful peripheral diabetic neuropathy in type 1 and 2 diabetes mellitus patients
(Elsevier, 2013)Aims: The present study was undertaken to investigate the relationship between glyoxalase 1 (Glo1) enzyme activity and painful diabetic neuropathy (DN) in patients with diabetes mellitus. Methods: Glo1 activity and ...